Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T15:52:18.153Z.

Stored calculation inputs

Calculation as of: 2026-10-06T15:52:18.153Z.

Quote observation: 2026-10-06T15:50:03.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 159,799,241
TTM free cash flow · period ending 2026-06-30: -18,779,281,838

FMP input reference: cfadd87817ab9e0f0725aca527bf69eaa76c8d0ff583b2c20c0f03a80ea5973c

P/E Ratio|FCF Growth|Operating Margin|All Metrics

NERV Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

PRICE/FCF RATIO AVG TTM

N/A

PRICE/FCF RATIO AVG 3Y

N/A

PRICE/FCF RATIO AVG 5Y

N/A

PRICE/FCF RATIO AVG 10Y

N/A

PRICE/FCF RATIO AVG 15Y

N/A

PRICE/FCF RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

N/A

CURRENT VS 3Y AVG

N/A

CURRENT VS 5Y AVG

N/A

CURRENT VS 10Y AVG

N/A

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

NERV Competitors' Price/FCF Ratio

NERV

Minerva Neurosciences, Inc.

Current

Market Cap

$159.80M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

INGN

Inogen, Inc.

vs NERV

Market Cap

$158.79M

Price/FCF Ratio

N/A

TTM Avg

69.31

3Y Avg

47.40

5Y Avg

57.04

MENS

Jyong Biotech Ltd. Ordinary Shares

vs NERV

Market Cap

$155.86M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ALXO

ALX Oncology Holdings Inc.

vs NERV

Market Cap

$155.61M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CRDL

Cardiol Therapeutics Inc.

vs NERV

Market Cap

$153.89M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AVXL

Anavex Life Sciences Corp.

vs NERV

Market Cap

$152.69M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

PEPG

PepGen Inc.

vs NERV

Market Cap

$162.55M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CDXS

Codexis, Inc.

vs NERV

Market Cap

$152.20M

Price/FCF Ratio

N/A

TTM Avg

55.06

3Y Avg

55.06

5Y Avg

55.06

CHRS

Coherus Oncology, Inc.

vs NERV

Market Cap

$164.54M

Price/FCF Ratio

N/A

TTM Avg

193.13

3Y Avg

193.13

5Y Avg

37.96

QTRX

Quanterix Corporation

vs NERV

Market Cap

$164.64M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Minerva Neurosciences, Inc. (NERV)	$159.80M	N/A	N/A	N/A	N/A
Inogen, Inc. (INGN)vs ›	$158.79M	N/A	69.31	47.40	57.04
Jyong Biotech Ltd. Ordinary Shares (MENS)vs ›	$155.86M	N/A	N/A	N/A	N/A
ALX Oncology Holdings Inc. (ALXO)vs ›	$155.61M	N/A	N/A	N/A	N/A
Cardiol Therapeutics Inc. (CRDL)vs ›	$153.89M	N/A	N/A	N/A	N/A
Anavex Life Sciences Corp. (AVXL)vs ›	$152.69M	N/A	N/A	N/A	N/A
PepGen Inc. (PEPG)vs ›	$162.55M	N/A	N/A	N/A	N/A
Codexis, Inc. (CDXS)vs ›	$152.20M	N/A	55.06	55.06	55.06
Coherus Oncology, Inc. (CHRS)vs ›	$164.54M	N/A	193.13	193.13	37.96
Quanterix Corporation (QTRX)vs ›	$164.64M	N/A	N/A	N/A	N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

NERV Price/FCF Ratio History

DATE	PRICE/FCF RATIO
2018-05-03	77.06
2018-05-02	85.20
2018-05-01	83.32
2018-04-30	82.07
2018-04-27	80.50
2018-04-26	85.20
2018-04-25	85.83
2018-04-24	91.47
2018-04-23	91.47
2018-04-20	90.21
2018-04-19	89.59
2018-04-18	90.84
2018-04-17	90.21
2018-04-16	86.45
2018-04-13	86.45
2018-04-12	88.96
2018-04-11	87.08
2018-04-10	85.83
2018-04-09	83.32
2018-04-06	85.20
2018-04-05	86.45
2018-04-04	92.09
2018-04-03	82.69
2018-04-02	77.68
2018-03-29	78.31
2018-03-28	79.56
2018-03-27	75.80
2018-03-26	81.44
2018-03-23	80.19
2018-03-22	81.44
2018-03-21	83.95
2018-03-20	83.32
2018-03-19	83.32
2018-03-16	78.94
2018-03-15	79.56
2018-03-14	80.82
2018-03-13	80.82
2018-03-12	79.05
2018-03-09	76.39
2018-03-08	73.74
2018-03-07	75.73
2018-03-06	72.41
2018-03-05	71.08
2018-03-02	69.09
2018-03-01	67.09
2018-02-28	69.75
2018-02-27	73.07
2018-02-26	76.39
2018-02-23	73.74
2018-02-22	69.09
2018-02-21	70.42
2018-02-20	68.75
2018-02-16	72.41
2018-02-15	73.07
2018-02-14	75.07
2018-02-13	74.40
2018-02-12	73.74
2018-02-09	73.74
2018-02-08	75.73
2018-02-07	81.71
2018-02-06	74.40
2018-02-05	76.39
2018-02-02	82.37
2018-02-01	85.69
2018-01-31	85.03
2018-01-30	83.04
2018-01-29	81.04
2018-01-26	87.69
2018-01-25	93.00
2018-01-24	90.34
2018-01-23	87.69
2018-01-22	88.35
2018-01-19	90.34
2018-01-18	87.02
2018-01-17	87.02
2018-01-16	86.36
2018-01-12	83.04
2018-01-11	80.38
2018-01-10	73.07
2018-01-09	71.08
2018-01-08	73.74
2018-01-05	79.72
2018-01-04	80.38
2018-01-03	81.71
2018-01-02	82.37
2017-12-29	80.38
2017-12-28	84.37
2017-12-27	81.71
2017-12-26	85.03
2017-12-22	80.38
2017-12-21	83.04
2017-12-20	77.06
2017-12-19	75.07
2017-12-18	77.06
2017-12-15	79.05
2017-12-14	76.39
2017-12-13	81.04
2017-12-12	77.72
2017-12-11	80.38
2017-12-08	75.73
2017-12-07	74.40
2017-12-06	69.09
2017-12-05	71.74
2017-12-04	74.40
2017-12-01	73.74
2017-11-30	76.39
2017-11-29	80.38
2017-11-28	74.40
2017-11-27	69.75
2017-11-24	71.08
2017-11-22	71.74
2017-11-21	69.09
2017-11-20	69.75
2017-11-17	69.09
2017-11-16	69.09
2017-11-15	67.76
2017-11-14	68.42
2017-11-13	65.77
2017-11-10	69.09
2017-11-09	66.43
2017-11-08	67.76
2017-11-07	71.74

Price/FCF Ratio: N/A

NERV Price/FCF Ratio Chart

NERV Price/FCF Ratio Metrics

NERV Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

NERV Price/FCF Ratio History

Related Metrics